Treatment of Familial Hypertriglyceridemia
Initial Assessment and Secondary Causes
- The American College of Cardiology recommends evaluating for uncontrolled diabetes or prediabetes, as poor glycemic control significantly amplifies triglyceride elevation in genetically predisposed individuals 1, 2
- Screening for hypothyroidism, renal disease, liver disease, and review of medications that can cause massive triglyceride rises in familial hypertriglyceridemia is necessary 1
- Assessing alcohol intake and eliminating consumption entirely is crucial, as alcohol significantly raises triglyceride levels 1, 2
- Recognizing that multifactorial chylomicronemia syndrome is 40-60 fold more common than pure monogenic familial chylomicronemia syndrome is important 1
Lifestyle Interventions: The Critical Foundation
- Targeting 5-10% weight loss, which reduces triglycerides by 20% and in some patients up to 50-70%, is recommended 3, 2
- Restricting added sugars to <6% of total daily calories and limiting total fat to 30-35% of calories for mild-moderate hypertriglyceridemia is advised 3, 2
- Engaging in at least 150 minutes per week of moderate-intensity aerobic activity or 75 minutes per week of vigorous-intensity activity is necessary 3
- Adding resistance training with 8-10 different exercises, 1-2 sets per exercise, 10-15 repetitions at moderate intensity, 2 days per week is recommended 3
Pharmacologic Therapy Algorithm
- The American College of Cardiology recommends fenofibrate as the first-line pharmacologic agent to reduce pancreatitis risk in severe hypertriglyceridemia (≥500 mg/dL) 1
- Initiating statin therapy if 10-year ASCVD risk ≥7.5% (moderate-to-high risk) is advised, which provides 10-30% dose-dependent triglyceride reduction 3, 2
- Targeting non-HDL-cholesterol <130 mg/dL in patients with triglycerides 200-499 mg/dL is recommended 2
Special Considerations for Familial Hypertriglyceridemia
- Avoiding bile acid sequestrants when triglycerides are >200 mg/dL is necessary, as they are relatively contraindicated 2
- Exercising caution when combining fibrates with statins due to increased myositis risk, though fenofibrate has a better safety profile than gemfibrozil is crucial 2
- Monitoring creatine kinase levels when using combination therapy, particularly in patients >65 years of age is recommended 2
Monitoring Strategy
- Reassessing fasting lipid panel in 6-12 weeks after implementing lifestyle modifications is necessary 3, 2
- Monitoring lipid levels annually or every 2 years if all values remain optimal (triglycerides <150 mg/dL) is advised 3
- Re-evaluating for undiagnosed or undertreated secondary causes if triglycerides remain >150 mg/dL despite adherence to lifestyle changes is recommended 3
Treatment of Familial Hypertriglyceridemia with Fenofibrate
Pharmacologic Therapy Algorithm
- The American Diabetes Association recommends that if triglycerides remain elevated >200 mg/dL after 3 months of optimized lifestyle modifications and statin therapy, consider adding fenofibrate or prescription omega-3 fatty acids (icosapent ethyl 2-4g daily) 4
- The American Heart Association suggests that fenofibrate has a better safety profile than gemfibrozil when combined with statins, but myositis risk remains increased 5